Published in J Epidemiol on September 01, 2012
Epidemiology of perforated peptic ulcer: age- and gender-adjusted analysis of incidence and mortality. World J Gastroenterol (2013) 1.19
Scoring systems for outcome prediction in patients with perforated peptic ulcer. Scand J Trauma Resusc Emerg Med (2013) 0.94
Perforated peptic ulcer. Lancet (2015) 0.92
What is the best predictor of mortality in perforated peptic ulcer disease? A population-based, multivariable regression analysis including three clinical scoring systems. J Gastrointest Surg (2014) 0.87
Protective effects of garlic extract, PMK-S005, against nonsteroidal anti-inflammatory drugs-induced acute gastric damage in rats. Dig Dis Sci (2014) 0.86
Clinical characteristics of peptic ulcer perforation in Korea. World J Gastroenterol (2017) 0.75
Prognostic factors in peptic ulcer perforations: a retrospective 14-year study. Int Surg (2015) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
How to measure comorbidity. a critical review of available methods. J Clin Epidemiol (2003) 9.58
Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet (2002) 5.58
Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med (2000) 3.26
Seroprevalence of Helicobacter pylori in South Korea. Helicobacter (2007) 2.21
Trends in perforated peptic ulcer: incidence, etiology, treatment, and prognosis. World J Surg (2000) 1.88
Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut (1993) 1.64
Trends and outcomes of hospitalizations for peptic ulcer disease in the United States, 1993 to 2006. Ann Surg (2010) 1.40
Changing patterns in perforated peptic ulcer disease. Am Surg (1990) 1.33
Factors affecting mortality and morbidity in patients with peptic ulcer perforation. J Gastroenterol Hepatol (2007) 1.31
Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol (2006) 1.28
Surgical approach and prognostic factors after peptic ulcer perforation. Eur J Surg (1999) 1.25
Perforated peptic ulcer: main factors of morbidity and mortality. World J Surg (2003) 1.21
Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study. J Clin Epidemiol (2002) 1.19
Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002. BMC Gastroenterol (2009) 1.18
Perforated peptic ulcer: how to improve outcome? Scand J Gastroenterol (2009) 1.16
Perforated peptic ulcer over 56 years. Time trends in patients and disease characteristics. Gut (1993) 1.11
Factors that predict morbidity and mortality in patients with perforated peptic ulcers. Eur J Surg (2002) 1.10
Validation of administrative data used for the diagnosis of upper gastrointestinal events following nonsteroidal anti-inflammatory drug prescription. Aliment Pharmacol Ther (2006) 1.09
Perforated peptic ulcer: long-term results after simple closure in the elderly. World J Surg (1997) 1.08
Positive predictive value of ICD-9th codes for upper gastrointestinal bleeding and perforation in the Sistema Informativo Sanitario Regionale database. J Clin Epidemiol (1999) 1.01
Surgery for peptic ulcer today. A study on the incidence, methods and mortality in surgery for peptic ulcer in Finland between 1987 and 1999. Dig Surg (2004) 1.01
Short-term mortality after perforated or bleeding peptic ulcer among elderly patients: a population-based cohort study. BMC Geriatr (2007) 0.99
Risk factors influencing the short-term results of gastroduodenal perforation. Surg Today (1994) 0.99
Multicentre trial of a perioperative protocol to reduce mortality in patients with peptic ulcer perforation. Br J Surg (2011) 0.98
Complications of peptic ulcer disease. Dig Dis (2011) 0.98
Morbidity and mortality of perforated peptic gastroduodenal ulcer following emergency surgery. Langenbecks Arch Surg (2002) 0.94
Changing prevalence of upper gastrointestinal disease in 28 893 Koreans from 1995 to 2005. Eur J Gastroenterol Hepatol (2009) 0.93
Clinical trial: the incidence and early mortality after peptic ulcer perforation, and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugs. Aliment Pharmacol Ther (2008) 0.91
Perforated gastric and duodenal ulcer: an analysis of prognostic factors. Am Surg (1993) 0.86
Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study. Arch Intern Med (1995) 0.85
Evaluation of risk factors for mortality in surgically treated perforated peptic ulcer. Hepatogastroenterology (2001) 0.85
Acute surgical treatment of complicated peptic ulcers with special reference to the elderly. World J Surg (1996) 0.85
Perforated peptic ulcer: different ethnic, climatic and fasting risk factors for morbidity in Al-ain medical district, United Arab Emirates. Asian J Surg (2009) 0.84
Perforated peptic ulcer in South India: an institutional perspective. World J Surg (2009) 0.83
Trends of Gastrointestinal Diseases at a Single Institution in Korea over the Past Two Decades. Gut Liver (2009) 0.83
Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study. Rheumatology (Oxford) (2006) 0.81
Perforated peptic ulcer in southeastern Taiwan. J Gastroenterol Hepatol (2010) 0.79
Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib. Pharmacoepidemiol Drug Saf (2008) 0.79
From emergency room to morgue: deaths due to undiagnosed perforated peptic ulcers. Report of four cases with review of the literature. Am J Forensic Med Pathol (1994) 0.78
Preoperative sonographic diagnosis of sealed-off perforated gastric ulcer. J Clin Ultrasound (1998) 0.77
Seroprevalence of Helicobacter pylori in South Korea. Helicobacter (2007) 2.21
Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol (2008) 2.02
Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter (2011) 1.82
Hemostatic efficacy and clinical outcome of endoscopic treatment of Dieulafoy's lesions: comparison of endoscopic hemoclip placement and endoscopic band ligation. Gastrointest Endosc (2011) 1.68
Early gastric cancer associated with gastritis cystica polyposa in the unoperated stomach treated by endoscopic submucosal dissection. Gastrointest Endosc (2009) 1.67
The correlation of endoscopic and histological diagnosis of gastric atrophy. Dig Dis Sci (2009) 1.65
Cannabinoid receptor 1 gene polymorphism and irritable bowel syndrome in the Korean population: a hypothesis-generating study. J Clin Gastroenterol (2011) 1.60
[Risk factors for development and recurrence of peptic ulcer disease]. Korean J Gastroenterol (2010) 1.59
Effect of the CYP2C19 polymorphism on the eradication rate of Helicobacter pylori infection by 7-day triple therapy with regular proton pump inhibitor dosage. J Gastroenterol Hepatol (2008) 1.58
[Clinical review of gastrointestinal carcinoid tumor and analysis of the factors predicting metastasis]. Korean J Gastroenterol (2007) 1.57
Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding. Gut (2011) 1.56
Detection rate of Helicobacter pylori against a background of atrophic gastritis and/or intestinal metaplasia. J Clin Gastroenterol (2007) 1.55
Anti-IgE treatment of eosinophil-associated gastrointestinal disorders. J Allergy Clin Immunol (2007) 1.52
Role of intestinal metaplasia subtyping in the risk of gastric cancer in Korea. J Gastroenterol Hepatol (2008) 1.52
Portal hypertensive enteropathy diagnosed by capsule endoscopy in cirrhotic patients: a nationwide multicenter study. Dig Dis Sci (2014) 1.49
Blood pressure variability and the development of early neurological deterioration following acute ischemic stroke. J Hypertens (2015) 1.47
Importance of Patients' Knowledge of Their Prescribed Medication in Improving Treatment Adherence in Inflammatory Bowel Disease. J Clin Gastroenterol (2016) 1.44
[Clinicopathological characteristics of gastric cancer and survival improvement by surgical treatment in the elderly]. Korean J Gastroenterol (2011) 1.44
[Efficacy and predictors of the virologic response to entecavir therapy in nucleoside-naive patients with chronic hepatitis B]. Korean J Hepatol (2010) 1.43
[Effects of proton pump inhibitors in asthmatics with gastroesophageal reflux disease]. Korean J Gastroenterol (2011) 1.42
Clinical features and prognosis of early colorectal cancer treated by endoscopic mucosal resection. J Gastroenterol Hepatol (2011) 1.41
Clinical Characteristics and Treatment Outcomes of Cryptogenic Multifocal Ulcerous Stenosing Enteritis in Korea. Dig Dis Sci (2015) 1.40
Incidence and risk factors of irritable bowel syndrome in community subjects with culture-proven bacterial gastroenteritis. Korean J Gastroenterol (2012) 1.40
Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012. Helicobacter (2012) 1.40
World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol (2012) 1.39
[The effect of aspirin alone or aspirin plus additional antiplatelets therapy on upper gastrointestinal hemorrhage]. Korean J Gastroenterol (2011) 1.39
[Inhibition of in vitro hepatitis B virus replication by lentivirus-mediated short-hairpin RNA against HBx]. Korean J Hepatol (2009) 1.38
Functional Gastrointestinal Disorders Diagnosed by Rome III Questionnaire in Korea. J Neurogastroenterol Motil (2011) 1.36
Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea. J Clin Gastroenterol (2010) 1.36
[Recent etiology and clinical features of acute viral hepatitis in a single center of Korea]. Korean J Hepatol (2007) 1.32
Pneumoretroperitoneum, pneumomediastinum, peumopericardium, and subcutaneous emphysema after colonoscopic examination. Gut Liver (2007) 1.32
Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years. BMC Gastroenterol (2013) 1.31
[Change of Clostridium difficile colitis during recent 10 years in Korea]. Korean J Gastroenterol (2010) 1.31
Phospholipase C-gamma2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells. Blood (2005) 1.31
Comparison of 22-gauge aspiration needle with 22-gauge biopsy needle in endoscopic ultrasonography-guided subepithelial tumor sampling. Scand J Gastroenterol (2013) 1.31
Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer. J Clin Gastroenterol (2010) 1.28
Pharmacokinetics and pharmacodynamics of the proton pump inhibitors. J Neurogastroenterol Motil (2013) 1.27
What is the best reconstruction method after distal gastrectomy for gastric cancer? Surg Endosc (2011) 1.23
The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication. Helicobacter (2008) 1.23
Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection. J Pathol (2009) 1.23
Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea. Antimicrob Agents Chemother (2004) 1.23
Long-term outcome of palliative therapy for gastric outlet obstruction caused by unresectable gastric cancer in patients with good performance status: endoscopic stenting versus surgery. Gastrointest Endosc (2013) 1.22
Learning curves for colonoscopy: a prospective evaluation of gastroenterology fellows at a single center. Gut Liver (2010) 1.22
Prevalence of gastroesophageal reflux disease in Korea and associated health-care utilization: a national population-based study. J Gastroenterol Hepatol (2012) 1.21
Capsule endoscopy in small bowel tumors: a multicenter Korean study. J Gastroenterol Hepatol (2010) 1.21
Plant sterol guggulsterone inhibits nuclear factor-kappaB signaling in intestinal epithelial cells by blocking IkappaB kinase and ameliorates acute murine colitis. Inflamm Bowel Dis (2006) 1.20
Emerging need for vaccination against hepatitis A virus in patients with chronic liver disease in Korea. J Korean Med Sci (2007) 1.18
Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. J Antimicrob Chemother (2005) 1.16
Prevalence and predictive factors of fecal incontinence. J Neurogastroenterol Motil (2012) 1.15
Clinical characteristics and treatment outcomes of 3 subtypes of achalasia according to the chicago classification in a tertiary institute in Korea. J Neurogastroenterol Motil (2013) 1.14
Korean red ginseng (Panax ginseng) ameliorates type 1 diabetes and restores immune cell compartments. J Ethnopharmacol (2012) 1.14
Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea. Helicobacter (2010) 1.14
Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis. Helicobacter (2014) 1.14
The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea. Helicobacter (2008) 1.12
Anxiety, depression and quality of life in patients with irritable bowel syndrome. Gut Liver (2011) 1.12
Meta-analysis: is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults? J Gastroenterol Hepatol (2013) 1.11
The effects of genetic polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced gastroduodenal diseases in Korea. J Clin Gastroenterol (2009) 1.11
Progression of atrophic gastritis and intestinal metaplasia drives Helicobacter pylori out of the gastric mucosa. Dig Dis Sci (2006) 1.11
Two cases of uncommon complication during percutaneous endoscopic gastrostomy tube replacement and treatment. Korean J Gastroenterol (2014) 1.10
Long-term prognosis of an endoscopically treated rectal neuroendocrine tumor: 10-year experience in a single institution. Eur J Gastroenterol Hepatol (2012) 1.09
An association between obesity and the prevalence of colonic adenoma according to age and gender. J Gastroenterol (2007) 1.08
Congenital angiodysplasia in a woman presenting with idiopathic jejunal varicosis on angiography. Gut Liver (2009) 1.08
Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients. Int J Antimicrob Agents (2006) 1.07
Performance and cost of disposable biopsy forceps in upper gastrointestinal endoscopy: comparison with reusable biopsy forceps. Clin Endosc (2012) 1.07
ALU and LINE-1 hypomethylations in multistep gastric carcinogenesis and their prognostic implications. Int J Cancer (2012) 1.07
Double knockouts reveal that protein tyrosine phosphatase 1B is a physiological target of calpain-1 in platelets. Mol Cell Biol (2007) 1.06
CDX1 and CDX2 expression in intestinal metaplasia, dysplasia and gastric cancer. J Korean Med Sci (2011) 1.06
Bowel preparation for capsule endoscopy: a prospective randomized multicenter study. Gut Liver (2009) 1.06
Gene mutations of 23S rRNA associated with clarithromycin resistance in Helicobacter pylori strains isolated from Korean patients. J Microbiol Biotechnol (2008) 1.05
Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomach. Gastric Cancer (2013) 1.04
Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate. Helicobacter (2009) 1.04
Cross-cultural validation of Irritable Bowel Syndrome Quality of Life in Korea. Dig Dis Sci (2006) 1.04
Ketogenic diet-induced peroxisome proliferator-activated receptor-γ activation decreases neuroinflammation in the mouse hippocampus after kainic acid-induced seizures. Exp Neurol (2011) 1.03
Intestinal pseudo-obstruction: initial manifestation of systemic lupus erythematosus. J Neurogastroenterol Motil (2011) 1.03
Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "concomitant" therapy and 7-day standard triple therapy. J Clin Gastroenterol (2013) 1.03
Fast synthesis of high-performance graphene films by hydrogen-free rapid thermal chemical vapor deposition. ACS Nano (2014) 1.02
c-Myc-mediated overexpression of miR-17-92 suppresses replication of hepatitis B virus in human hepatoma cells. J Med Virol (2013) 1.02
Histologic characteristics of gastric polyps in Korea: emphasis on discrepancy between endoscopic forceps biopsy and endoscopic mucosal resection specimen. World J Gastroenterol (2006) 1.02
Heat shock protein gene 70-2 polymorphism is differentially associated with the clinical phenotypes of ulcerative colitis and Crohn's disease. J Gastroenterol Hepatol (2007) 1.02
The prevalence of and risk factors for Barrett's esophagus in a Korean population: A nationwide multicenter prospective study. J Clin Gastroenterol (2009) 1.02
Vacuolating cytotoxin in Helicobacter pylori water-soluble proteins upregulates chemokine expression in human eosinophils via Ca2+ influx, mitochondrial reactive oxygen intermediates, and NF-kappaB activation. Infect Immun (2007) 1.02
Is Metabolic Syndrome One of the Risk Factors for Gallbladder Polyps Found by Ultrasonography during Health Screening? Gut Liver (2007) 1.02
Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study. J Gastroenterol Hepatol (2012) 1.00
Management of non-variceal upper gastrointestinal bleeding. Clin Endosc (2012) 1.00
Effect of aging on gastric mucosal defense mechanisms: ROS, apoptosis, angiogenesis, and sensory neurons. Am J Physiol Gastrointest Liver Physiol (2010) 1.00
p110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease. Proc Natl Acad Sci U S A (2009) 1.00
Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes. J Immunol (2008) 1.00
Effect of Helicobacter pylori Eradication on Functional Dyspepsia. J Neurogastroenterol Motil (2013) 1.00
Association between alcohol intake and risk for gastric cancer with regard to ALDH2 genotype in the Korean population. Int J Epidemiol (2011) 1.00
The Clinical Meaning of Benign Colon Uptake in (18)F-FDG PET: Comparison with Colonoscopic Findings. Clin Endosc (2012) 0.99
Oligonol inhibits dextran sulfate sodium-induced colitis and colonic adenoma formation in mice. Antioxid Redox Signal (2013) 0.99
Two Cases of Chronic Idiopathic Intestinal Pseudo-obstruction with Different Clinical Features. J Neurogastroenterol Motil (2010) 0.99
Resveratrol reduces TNF-α-induced U373MG human glioma cell invasion through regulating NF-κB activation and uPA/uPAR expression. Anticancer Res (2011) 0.98
First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review. Clin Ther (2009) 0.97